PHARMA-SKAN ApS: Financial statements 2023
CVR: 16275247
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMA-SKAN ApS (CVR 16275247) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 15,308,053 and a net result of DKK 11,498,311 compared with DKK 10,877,228 the year before. That is an increase of 3.4% compared with the year before. Equity in the 2023 report amounted to DKK 19,879,511. The solvency ratio was 84.4%. The company had 14 employees in the financial year.
- Gross Profit
- DKK 15,308,053
- Profit/Loss
- DKK 11,498,311
- Equity
- DKK 19,879,511
- Total Assets
- DKK 23,561,398
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 15.3 mio. | 11.5 mio. | 19.9 mio. | 14 |
| 2022 | - | 14.8 mio. | 10.9 mio. | 18.9 mio. | 13 |
| 2021 | - | 12.4 mio. | 9.1 mio. | 17 mio. | 13 |
| 2020 | - | 12.6 mio. | 9.3 mio. | 17.9 mio. | 14 |
| 2019 | - | 9.9 mio. | 7.2 mio. | 14.7 mio. | 12 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMA-SKAN ApS has published its annual report for 2022. Gross profit came to DKK 14,799,792, and the net result was DKK 10,877,228.
About PHARMA-SKAN ApS
PHARMA-SKAN ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS KBUS 38 NR. 2587. The management consists of Line Wulff and Ib Gunnar Christensen. The board consists of Jan Dam (chair), Kent Ernst Hansen, Lars Enghave Minor and Line Wulff. The company is owned by BESULA ApS. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK 12,339,941 and a net result of DKK 7,875,190 compared with DKK 11,288,304 the year before. Equity in the 2025 report amounted to DKK 8,543,005.